Koli K - Search Results

1

Malignant pleural mesothelioma in Finland: regional and gender variation.

Laaksonen S, Ilonen I, Kuosma E, Sutinen E, Wolff H, Vehmas T, Husgafvel-Pursiainen K, Salo JA, Koli K, Räsänen J, Myllärniemi M. Laaksonen S, et al. Among authors: koli k. Acta Oncol. 2019 Jan;58(1):38-44. doi: 10.1080/0284186X.2018.1532599. Epub 2018 Oct 30. Acta Oncol. 2019. PMID: 30375909

2

Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy.

Paajanen J, Ilonen I, Lauri H, Järvinen T, Sutinen E, Ollila H, Rouvinen E, Lemström K, Räsänen J, Ritvos O, Koli K, Myllärniemi M. Paajanen J, et al. Among authors: koli k. Clin Lung Cancer. 2020 May;21(3):e142-e150. doi: 10.1016/j.cllc.2019.10.013. Epub 2019 Oct 25. Clin Lung Cancer. 2020. PMID: 31734071 Free article.

3

Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth.

Tamminen JA, Yin M, Rönty M, Sutinen E, Pasternack A, Ritvos O, Myllärniemi M, Koli K. Tamminen JA, et al. Among authors: koli k. Exp Cell Res. 2015 Mar 1;332(1):102-15. doi: 10.1016/j.yexcr.2014.12.010. Epub 2014 Dec 31. Exp Cell Res. 2015. PMID: 25557874 Free article.

4

Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma.

Vehviläinen P, Koli K, Myllärniemi M, Lindholm P, Soini Y, Salmenkivi K, Kinnula VL, Keski-Oja J. Vehviläinen P, et al. Among authors: koli k. Hum Pathol. 2011 Feb;42(2):269-78. doi: 10.1016/j.humpath.2010.07.005. Epub 2010 Nov 24. Hum Pathol. 2011. PMID: 21106222

5

Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo.

Li C, Rezov V, Joensuu E, Vartiainen V, Rönty M, Yin M, Myllärniemi M, Koli K. Li C, et al. Among authors: koli k. Sci Rep. 2018 Jul 3;8(1):10070. doi: 10.1038/s41598-018-28297-x. Sci Rep. 2018. PMID: 29968778 Free PMC article.

6

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment - A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine.

Koli K, Sutinen E, Rönty M, Rantakari P, Fortino V, Pulkkinen V, Greco D, Sipilä P, Myllärniemi M. Koli K, et al. PLoS One. 2016 Jul 18;11(7):e0159010. doi: 10.1371/journal.pone.0159010. eCollection 2016. PLoS One. 2016. PMID: 27428020 Free PMC article.

7

Pulmonary administration of a dry powder formulation of the antifibrotic drug tilorone reduces silica-induced lung fibrosis in mice.

Vartiainen V, Raula J, Bimbo LM, Viinamäki J, Backman JT, Ugur N, Kauppinen E, Sutinen E, Joensuu E, Koli K, Myllärniemi M. Vartiainen V, et al. Among authors: koli k. Int J Pharm. 2018 Jun 10;544(1):121-128. doi: 10.1016/j.ijpharm.2018.04.019. Epub 2018 Apr 12. Int J Pharm. 2018. PMID: 29655797 Free article.

8

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry.

Kaunisto J, Salomaa ER, Hodgson U, Kaarteenaho R, Kankaanranta H, Koli K, Vahlberg T, Myllärniemi M. Kaunisto J, et al. Among authors: koli k. ERJ Open Res. 2019 Jul 8;5(3):00170-2018. doi: 10.1183/23120541.00170-2018. eCollection 2019 Jul. ERJ Open Res. 2019. PMID: 31304177 Free PMC article.

9

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways.

Saraswat M, Joenväärä S, Tohmola T, Sutinen E, Vartiainen V, Koli K, Myllärniemi M, Renkonen R. Saraswat M, et al. Among authors: koli k. Sci Rep. 2020 May 8;10(1):7787. doi: 10.1038/s41598-020-64759-x. Sci Rep. 2020. PMID: 32385381 Free PMC article.

10

Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma.

Yin M, Tissari M, Tamminen J, Ylivinkka I, Rönty M, von Nandelstadh P, Lehti K, Hyytiäinen M, Myllärniemi M, Koli K. Yin M, et al. Among authors: koli k. Oncotarget. 2017 Oct 6;8(58):98280-98297. doi: 10.18632/oncotarget.21550. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page